Literature DB >> 16528370

Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.

Ellen Sigauke1, Dinesh Rakheja, Debra L Maddox, Christa L Hladik, Charles L White, Charles F Timmons, Jack Raisanen.   

Abstract

Malignant rhabdoid tumors are high-grade neoplasms of the central nervous system (CNS), kidneys and soft tissue that usually occur in children. The histologic diagnosis of malignant rhabdoid tumor depends on identification of characteristic rhabdoid cells-large cells with eccentrically located nuclei and abundant, eosinophilic cytoplasm-and immunohistochemistry with antibodies to vimentin, keratin and epithelial membrane antigen. In most malignant rhabdoid tumors, the SMARCB1/INI1 gene, located in chromosome band 22q11.2, is inactivated by deletions and/or mutations, so genetic diagnosis is often possible. However, tissue may not be available for genetic analysis or studies not confirmatory. We assessed SMARCB1/INI1 expression in 17 rhabdoid tumors and 57 other tumors of the CNS, kidney or soft tissue using immunohistochemistry. In total, 12 brain, three renal and two soft tissue rhabdoid tumors were examined along with four glioblastomas, four pilocytic astrocytomas, four oligodendrogliomas, two ependymomas, two choroid plexus papillomas, five pituitary adenomas, four germinomas, four renal carcinomas with Xp11.2 translocations, two clear cell sarcomas, two Wilms' tumors, one renal medullary carcinoma, two desmoplastic small round cell tumors, two alveolar rhabdomyosarcomas, two embryonal rhabdomyosarcomas, one low-grade chondrosarcoma, two extraskeletal myxoid chondrosarcomas, one mesenchymal chondrosarcoma, four malignant peripheral nerve sheath tumors, five metastatic carcinomas and four epithelioid sarcomas, two primary and two metastatic. The neoplastic cells of all rhabdoid tumors, the four epithelioid sarcomas and the renal medullary carcinoma did not express SMARCB1/INI1 by immunohistochemistry; neoplastic cells of all other tumors expressed SMARCB1/INI1. Immunohistochemistry to assess expression of SMARCB1/INI1 may be useful in the diagnosis of rhabdoid tumors of the CNS, kidneys and soft tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528370     DOI: 10.1038/modpathol.3800581

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  37 in total

1.  Disseminated Malignant Rhabdoid Tumor of the Head and Neck.

Authors:  Daniel Thomas Ginat; Nicole A Cipriani; Alixandra Purakal; Carrie Fitzpatrick; Kristen Paral; Thomas Krausz; Peter Pytel
Journal:  Head Neck Pathol       Date:  2016-09-08

Review 2.  Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors.

Authors:  Khin Thway; Andrew L Folpe
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

3.  Primary malignant rhabdoid tumor of greater omentum in 10-year-old girl.

Authors:  So-Hyun Nam; Jeong-A Park; Yeon Mee Kim
Journal:  Ann Surg Treat Res       Date:  2014-01-01       Impact factor: 1.859

4.  Beware of immunohistochemistry--report of a cytokeratin-, desmin- and INI-1-negative pelvic desmoplastic small round cell tumor in a 51 year old woman.

Authors:  Gwyneth St Soon; Fredrik Petersson
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.

Authors:  Ludvik R Donner; Luanne M Wainwright; Fan Zhang; Jaclyn A Biegel
Journal:  Hum Pathol       Date:  2007-03-21       Impact factor: 3.466

6.  Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.

Authors:  Portia A Kreiger; Alexander R Judkins; Pierre A Russo; Jaclyn A Biegel; Brian J Lestini; Chatchawin Assanasen; Bruce R Pawel
Journal:  Mod Pathol       Date:  2008-11-07       Impact factor: 7.842

7.  Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors.

Authors:  Angela D Trobaugh-Lotrario; Gail E Tomlinson; Milton J Finegold; Lia Gore; James H Feusner
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

8.  Malignant rhabdoid tumour of the liver in the young adult: report of first two cases.

Authors:  Ettore Marzano; Emilie Lermite; Cinzia Nobili; Carlos Teyssedou; Philippe Bachellier; Jean-Pierre Arnaud; Patrick Pessaux
Journal:  HPB Surg       Date:  2009-09-10

9.  Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.

Authors:  Kenichi Kohashi; Yoshinao Oda; Hidetaka Yamamoto; Sadafumi Tamiya; Teiyu Izumi; Shigeru Ohta; Tomoaki Taguchi; Sachiyo Suita; Masazumi Tsuneyoshi
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-08       Impact factor: 4.553

10.  Extrarenal rhabdoid tumours outside the central nervous system in infancy.

Authors:  Enrique F Garcés-Iñigo; Rebecca Leung; Neil J Sebire; Kieran McHugh
Journal:  Pediatr Radiol       Date:  2009-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.